科华生物(002022)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002022 科华生物

已收盘 07-10 15:00:00

{"stockData":{"symbol":"002022","market":"SZ","secType":"STK","nameCN":"科华生物","latestPrice":6.48,"timestamp":1752131001000,"preClose":6.4,"halted":0,"volume":7006127,"delay":0,"changeRate":0.0125,"floatShares":513999999,"shares":513999999,"eps":-1.2931,"marketStatus":"已收盘","change":0.08,"latestTime":"07-10 15:00:00","open":6.4,"high":6.52,"low":6.36,"amount":45244300,"amplitude":0.025,"askPrice":6.48,"askSize":890,"bidPrice":6.47,"bidSize":641,"shortable":0,"etf":0,"ttmEps":-1.2931,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752197400000},"marketStatusCode":5,"adr":0,"adjPreClose":6.4,"symbolType":"stock","openAndCloseTimeList":[[1752111000000,1752118200000],[1752123600000,1752130800000]],"highLimit":7.04,"lowLimit":5.76,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":514318459,"isCdr":false,"pbRate":1.01,"roa":"--","roe":"--","epsLYR":-1.2687,"committee":-0.483506,"marketValue":3333000000,"turnoverRate":0.0136,"status":0,"floatMarketCap":3332000000},"requestUrl":"/m/hq/s/002022","defaultTab":"news","newsList":[{"id":"2548026558","title":"科华生物：积极探索居家检测业务机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2548026558","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548026558?lang=zh_cn&edition=full","pubTime":"2025-07-03 20:51","pubTimestamp":1751547069,"startTime":"0","endTime":"0","summary":"证券之星消息，科华生物07月02日在投资者关系平台上答复投资者关心的问题。公司深耕体外诊断行业多年，一直密切关注前沿技术的发展与应用，结合公司实际业务需要和发展战略，积极探索相关业务机会。公司将持续重点关注呼吸、消化和生殖等领域的居家检测产品，不断丰富产品，并与数字化设备和软件相结合，构建个人健康管理生态系统。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300036218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0028","BK0188","BK0046","BK0239"],"gpt_icon":0},{"id":"2548935866","title":"科华生物：控股股东西安致同合计控制公司15.64%表决权","url":"https://stock-news.laohu8.com/highlight/detail?id=2548935866","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548935866?lang=zh_cn&edition=full","pubTime":"2025-07-02 16:06","pubTimestamp":1751443570,"startTime":"0","endTime":"0","summary":"谢谢科华生物回复：尊敬的投资者，您好！公司控股股东西安致同持有公司5%股份，并通过表决权委托方式控制公司10.64%表决权，合计控制公司15.64%表决权，为公司控制表决权数量最多的股东；珠海保联持有公司13.64%股份，拥有公司3%表决权。在表决权委托期间，西安致同与珠海保联构成一致行动人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200024302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0046","BK0239","002022"],"gpt_icon":0},{"id":"2546429666","title":"科华生物：构建临床质谱一体化平台覆盖五大核心领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2546429666","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546429666?lang=zh_cn&edition=full","pubTime":"2025-06-25 15:36","pubTimestamp":1750836997,"startTime":"0","endTime":"0","summary":"证券之星消息，科华生物06月25日在投资者关系平台上答复投资者关心的问题。在临床质谱领域，公司以超高效液相色谱串联质谱为核心技术，构建了“前处理自动化+质谱检测+试剂配套”的一体化平台，覆盖营养代谢、药物浓度监测、内分泌激素检测、生物标志物分析和临床毒理研究等五大核心领域，赋能精准医疗。关于公司业绩情况请关注公司后续披露的定期报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062500020193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002022","BK0028","BK0188","BK0046"],"gpt_icon":0},{"id":"2542730614","title":"科华生物：公司会在获得注册证后及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2542730614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542730614?lang=zh_cn&edition=full","pubTime":"2025-06-11 16:37","pubTimestamp":1749631026,"startTime":"0","endTime":"0","summary":"证券之星消息，科华生物06月11日在投资者关系平台上答复投资者关心的问题。有关公司新产品的注册情况，公司会在获得注册证后及时履行信息披露义务，请关注公司相关公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100024813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0046","BK0239","BK0028","002022"],"gpt_icon":0},{"id":"2539297941","title":"科华生物：公司制定了符合实际情况的估值提升计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2539297941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539297941?lang=zh_cn&edition=full","pubTime":"2025-05-30 08:33","pubTimestamp":1748565192,"startTime":"0","endTime":"0","summary":"证券之星消息，科华生物05月29日在投资者关系平台上答复投资者关心的问题。长期破净公司应当至少每年对估值提升计划的实施效果进行评估。贵司虽在4月28日提交了估值提升计划，文件中计划事件较多，但实际可执行性贵司是否有认真考虑推进。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053000006252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002022","BK0188","BK0239","BK0046"],"gpt_icon":0},{"id":"2538481388","title":"科华生物：公司将持续加强服务能力，深化渠道建设，拓展销售网络","url":"https://stock-news.laohu8.com/highlight/detail?id=2538481388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538481388?lang=zh_cn&edition=full","pubTime":"2025-05-27 08:57","pubTimestamp":1748307433,"startTime":"0","endTime":"0","summary":"证券之星消息，科华生物(002022)05月26日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司在血站核酸血筛领域的市场占有率是多少？排名第几？科华生物回复：尊敬的投资者，您好！经过多年的市场开拓与经营，公司已建立了以生物学和医学为背景、管理成熟、覆盖全国市场的专业营销团队，为公司保有广泛而稳定的客户资源奠定了基础，同时驱动了公司不断开发新用户以提升市场占有率。公司将持续加强服务能力，深化渠道建设，拓展销售网络。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052700005514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0239","BK0188","002022"],"gpt_icon":0},{"id":"2537949156","title":"科华生物：公司战略布局临床质谱领域构建一体化平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2537949156","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537949156?lang=zh_cn&edition=full","pubTime":"2025-05-22 20:51","pubTimestamp":1747918313,"startTime":"0","endTime":"0","summary":"证券之星消息，科华生物05月21日在投资者关系平台上答复投资者关心的问题。公司目前未进行核酸质谱和飞行时间质谱的研发。此外，公司战略布局临床质谱领域，以超高效液相色谱串联质谱为核心技术，构建了“前处理自动化+质谱检测+试剂配套”的一体化平台，覆盖营养代谢、药物浓度监测、内分泌激素检测、生物标志物分析和临床毒理研究等五大核心领域，赋能精准医疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052200035248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002022","BK0239","BK0046","BK0188"],"gpt_icon":0},{"id":"2535352537","title":"科华生物收盘下跌1.32%，最新市净率0.94，总市值30.76亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535352537","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535352537?lang=zh_cn&edition=full","pubTime":"2025-05-16 16:23","pubTimestamp":1747383811,"startTime":"0","endTime":"0","summary":"5月16日，科华生物今日收盘5.98元，下跌1.32%，最新市净率0.94，总市值30.76亿元。截至2025年一季报，共有5家机构持仓科华生物，其中其他5家，合计持股数11465.51万股，持股市值6.49亿元。上海科华生物工程股份有限公司的主营业务是体外诊断试剂、医疗检验仪器的研发、生产和销售。最新一期业绩显示，2025年一季报，公司实现营业收入3.88亿元，同比-12.50%；净利润-53259784.78元，同比-84.79%，销售毛利率37.39%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/16162350447000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0046","BK0188","BK0028","BK0239","002022"],"gpt_icon":0},{"id":"2535030310","title":"科华生物：公司及子公司独立经营不存在为天隆公司承担运营费用的情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2535030310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535030310?lang=zh_cn&edition=full","pubTime":"2025-05-14 08:36","pubTimestamp":1747182977,"startTime":"0","endTime":"0","summary":"科华生物回复：尊敬的投资者，您好！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051400006598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002022","BK0028","BK0046","BK0239"],"gpt_icon":0},{"id":"2534312871","title":"异动快报：科华生物（002022）5月9日14点27分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2534312871","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534312871?lang=zh_cn&edition=full","pubTime":"2025-05-09 14:30","pubTimestamp":1746772250,"startTime":"0","endTime":"0","summary":"证券之星5月9日盘中消息，14点27分科华生物触及涨停板。目前价格6.37，上涨10.02%。其所属行业医疗器械目前下跌。该股为流感，新冠病毒防治，抗原自测概念热股，当日流感概念上涨0.1%。5月9日的资金流向数据方面，主力资金净流入2410.59万元，占总成交额11.16%，游资资金净流入221.58万元，占总成交额1.03%，散户资金净流出2632.17万元，占总成交额12.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900017047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002022","BK0046","BK0028","BK0188"],"gpt_icon":0},{"id":"2534971281","title":"科华生物：公司与国内外品牌开展合作可以丰富和拓展自产产品线的应用组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2534971281","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534971281?lang=zh_cn&edition=full","pubTime":"2025-05-09 08:54","pubTimestamp":1746752055,"startTime":"0","endTime":"0","summary":"证券之星消息，科华生物(002022)05月08日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，贵司代理产品利润较低，是否有考虑用自产产品替代代理产品的方式来增加公司收入？科华生物回复：尊敬的投资者，您好！公司与国内外品牌开展合作，可以丰富和拓展自产产品线的应用组合，为客户提供全方位的体外诊断产品与服务。公司将充分利用代理业务和渠道业务的优势，发挥代理产品和自产产品的协同效应，提升公司的产品、服务质量，为客户提供完善的整体解决方案。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900005724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","002022","BK0239","BK0028"],"gpt_icon":0},{"id":"2534197123","title":"科华生物：将严格按照法律法规履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2534197123","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534197123?lang=zh_cn&edition=full","pubTime":"2025-05-09 08:46","pubTimestamp":1746751591,"startTime":"0","endTime":"0","summary":"金融界5月9日消息，有投资者在互动平台向科华生物提问：你好，贵司当下虽然实控人为西安致同，但是股份持有最多依然为格力地产旗下的珠海保联，该结构不利于公司发展，是否考虑通过股份购买成为最大股东？公司回答表示：尊敬的投资者，您好！感谢您对公司的关注！若公司有重大事项达到信息披露的标准，公司严格按照法律法规的规定及时履行信息披露义务，请以公司披露的公告为准。\n\n\r\n            责任编辑：栎树","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/09084650245172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002022","BK0046","BK0028","BK0188","BK0239"],"gpt_icon":0},{"id":"2531785182","title":"图解科华生物一季报：第一季度单季净利润同比减84.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531785182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531785182?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:59","pubTimestamp":1745924382,"startTime":"0","endTime":"0","summary":"证券之星消息，科华生物2025年一季报显示，公司主营收入3.88亿元，同比下降12.5%；归母净利润-5325.98万元，同比下降84.79%；扣非净利润-5663.63万元，同比下降44.79%；负债率24.22%，投资收益25.26万元，财务费用275.6万元，毛利率37.39%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900036925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022"],"gpt_icon":0},{"id":"2531209352","title":"科华生物(002022.SZ)发布一季度业绩，归母净亏损5325.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531209352","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531209352?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:36","pubTimestamp":1745919405,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科华生物(002022.SZ)发布2025年一季度报告，第一季度，公司实现营业收入3.88亿元，同比下降12.50%。归属于上市公司股东净亏损5325.98万元。归属于上市公司股东的扣除非经常性损益净亏损5663.63万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0239","BK0046","BK0188","002022"],"gpt_icon":0},{"id":"2530969445","title":"【科华生物在西安成立匠芯科技公司】 公开资料显示，近日，西安天睿匠芯科技有限公司成立，法定代表人为苗保刚，注册资本为100万元，经营范围包含：仪器仪表修理；计算机及办公设备维修；信息技术咨询服务；仪器仪表销售；第一类医疗器械租赁；第一类医疗器械销售等。股权数据显示，该公司由科华生物旗下西安天隆科技有限公司全资持股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530969445","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530969445?lang=zh_cn&edition=full","pubTime":"2025-04-28 14:42","pubTimestamp":1745822534,"startTime":"0","endTime":"0","summary":"公开资料显示，近日，西安天睿匠芯科技有限公司成立，法定代表人为苗保刚，注册资本为100万元，经营范围包含：仪器仪表修理；计算机及办公设备维修；信息技术咨询服务；仪器仪表销售；第一类医疗器械租赁；第一类医疗器械销售等。股权数据显示，该公司由科华生物旗下西安天隆科技有限公司全资持股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/28144249945551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["09996","09997","BK1100","BK1222","ARKG","BK0188","BK0239","BK1574","BK4585","BK4544","159883","BK1583","002022","159998","BK0028","BK0046","159939","BK4588"],"gpt_icon":0},{"id":"2530804474","title":"科华生物(002022)3月31日股东户数4.26万户，较上期减少3.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530804474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530804474?lang=zh_cn&edition=full","pubTime":"2025-04-27 17:08","pubTimestamp":1745744904,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科华生物披露，截至2025年3月31日公司股东户数为4.26万户，较12月31日减少1756.0户，减幅为3.96%。在医疗器械行业个股中，科华生物股东户数高于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.15万户。从股价来看，2024年12月31日至2025年3月31日，科华生物区间跌幅为10.3%，在此期间股东户数减少1756.0户，减幅为3.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042700006930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0028","BK0239","002022"],"gpt_icon":0},{"id":"2530138017","title":"科华生物：公司股票不存在被实施其他风险警示的情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2530138017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530138017?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:52","pubTimestamp":1745585568,"startTime":"0","endTime":"0","summary":"证券之星消息，科华生物(002022)04月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问金先生今年公司再亏损就连续亏损三年明年就要st了吧？科华生物回复：尊敬的投资者，您好！根据《深圳证券交易所股票上市规则（2024年修订）》第九章之第八节“其他风险警示”第9.8.1条规定，截至目前，公司股票不存在被实施其他风险警示的情形。感谢您的关注！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500034571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002022","BK0046","BK0028","BK0188"],"gpt_icon":0},{"id":"2530911960","title":"科华生物：公司新产品全自动化学发光免疫分析仪获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2530911960","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530911960?lang=zh_cn&edition=full","pubTime":"2025-04-25 08:57","pubTimestamp":1745542630,"startTime":"0","endTime":"0","summary":"证券之星消息，科华生物04月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司的新取得注册证的产品KHB Astra 1200化学发光免疫分析仪是多少速度的产品？公司新产品全自动化学发光免疫分析仪获得医疗器械注册证，丰富了公司产品线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500009936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1583","002022","BK0239","09997","BK1100","09996","BK0028","BK1574","BK1222","BK0188","BK0046"],"gpt_icon":0},{"id":"2518029171","title":"科华生物(002022.SZ)：丙型肝炎病毒(HCV)核酸检测试剂盒(PCR-荧光法)获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2518029171","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518029171?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:53","pubTimestamp":1741593187,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科华生物(002022.SZ)发布公告，近日，公司控股子公司苏州天隆生物科技有限公司收到国家药品监督管理局颁发的医疗器械注册证(体外诊断试剂)。涉及药品：“丙型肝炎病毒(HCV)核酸检测试剂盒(PCR-荧光法)”。该产品用于定量检测人血清或血浆样本中的丙型肝炎病毒核酸(RNA)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1259721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","BK0046","BK1574","002022","159883","09997","BK0239","BK1100","BK0188","BK0028","BK1583","09996"],"gpt_icon":0},{"id":"2517523464","title":"科华生物新提交“科华生物”等8件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2517523464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517523464?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:32","pubTimestamp":1741386759,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日上海科华生物工程股份有限公司新提交“科华生物”等8件商标注册申请。商标申请详情如下：今年以来上海科华生物工程股份有限公司新申请注册商标8件，截止目前公司共持有注册商标154件，另有21件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030800059381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","002022","BK0239","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752148654544,"stockEarnings":[{"period":"1week","weight":0.0273},{"period":"1month","weight":0.0289},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.1408},{"period":"1year","weight":0.2144},{"period":"ytd","weight":0.0143}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0274},{"period":"3month","weight":0.0836},{"period":"6month","weight":0.1024},{"period":"1year","weight":0.1803},{"period":"ytd","weight":0.0422}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海科华生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"42590人(较上一季度减少75.81%)","perCapita":"12074股","listingDate":"2004-07-21","address":"上海市徐汇区钦州北路1189号","registeredCapital":"51431万元","survey":"　　上海科华生物工程股份有限公司的主营业务是体外诊断试剂、医疗检验仪器的研发、生产和销售。公司的主要产品是生化诊断、免疫诊断、生化免疫诊断自动化、分子诊断、质谱、POCT（胶体金）、代理。国家科技进步二等奖、国家高新技术企业、国家知识产权试点企业、国家发改委生物医学工程高技术产业化示范企业、陕西省和西安市创新型企业、陕西省生命科学检测仪器工程技术研究中心依托单位等荣誉。","listedPrice":11.12},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科华生物(002022)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科华生物(002022)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科华生物,002022,科华生物股票,科华生物股票老虎,科华生物股票老虎国际,科华生物行情,科华生物股票行情,科华生物股价,科华生物股市,科华生物股票价格,科华生物股票交易,科华生物股票购买,科华生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科华生物(002022)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科华生物(002022)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}